SPONSOR
University Hospital, Rouen
Total Trials
11
Recruiting
11
Phases
Phase 3, Phase 2
Conditions studied: MYT1L SyndromeKidney Transplant InfectionRectal CancerHepatocellular CarcinomaColorectal CancerRhizarthrosisIrritable Bowel SyndromeEating Disorders SymptomsCOPD (Chronic Obstructive Pulmonary Disease)Hysterotomy; Affecting Fetus
University Hospital, Rouen is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including MYT1L Syndrome, Kidney Transplant Infection, Rectal Cancer, Hepatocellular Carcinoma.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital, Rouen
How many clinical trials has University Hospital, Rouen sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by University Hospital, Rouen, of which 11 are actively recruiting participants. These trials cover conditions including MYT1L Syndrome, Kidney Transplant Infection, Rectal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital, Rouen research focus on?
University Hospital, Rouen clinical trials span MYT1L Syndrome, Kidney Transplant Infection, Rectal Cancer, Hepatocellular Carcinoma, Colorectal Cancer, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital, Rouen clinical trial?
To participate in a University Hospital, Rouen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Rouen trials with current recruitment status updated daily.
Clinical Trials by University Hospital, Rouen
NCT07008612
Recruiting
MYT1L Syndrome: a Rare Paediatric Genetic Syndrome Responsible for a Neurodevelopmental Disorder
MYT1L Syndrome
NCT05708508 Phase 3
Recruiting
Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients
Kidney Transplant Infection
NCT06123156 Phase 3
Recruiting
Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer
Rectal Cancer
NCT05375370
Recruiting
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA
Hepatocellular Carcinoma
NCT02945033 Phase 3
Recruiting
Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk
Colorectal Cancer
NCT05708430 Phase 2
Recruiting
Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis
Rhizarthrosis
NCT06291038
Recruiting
Efficacy of Glutamine Supplementation in Patients Suffering From Irritable Bowel Syndrome With Impaired Intestinal Permeability
Irritable Bowel Syndrome
NCT07196189
Recruiting
Effects of Fecal Microbiota Transplantation
Eating Disorders Symptoms
NCT06677268
Recruiting
Respiratory Rehabilitation and Sleep Quality in COPD Patients
COPD (Chronic Obstructive Pulmonary Disease)
NCT05969457 Phase 3
Recruiting
Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES Approach
Hysterotomy; Affecting Fetus
NCT03371641
Recruiting
In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
Fetal Alcohol Syndrome
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology